Isatuximab is a medication being studied for its potential to help treat multiple myeloma, a type of blood cancer. It is used in combination with other medications to see if it can improve the time patients live without their disease getting worse.

Bortezomib is a medication used to treat multiple myeloma. It works by interfering with the growth of cancer cells, which are eventually destroyed. It is part of the standard treatment regimen for this type of cancer.

Lenalidomide is another medication used in the treatment of multiple myeloma. It helps the immune system attack cancer cells and also prevents the growth of new blood vessels that tumors need to grow.

Dexamethasone is a type of steroid that is used to reduce inflammation and suppress the immune system. In the context of multiple myeloma, it helps enhance the effects of other cancer treatments.

Multiple Myeloma – Multiple myeloma is a type of cancer that affects plasma cells, which are a kind of white blood cell found in the bone marrow. In this disease, cancerous plasma cells multiply and accumulate in the bone marrow, leading to bone damage and affecting the production of normal blood cells. As the disease progresses, it can cause bone pain, fractures, anemia, kidney dysfunction, and increased susceptibility to infections. The abnormal plasma cells produce a protein known as monoclonal protein or M protein, which can be detected in the blood or urine. Over time, the accumulation of these proteins can lead to organ damage, particularly affecting the kidneys. The progression of multiple myeloma is typically characterized by periods of stability followed by relapses.